Synchron
Focus: Synchron is a neuroprosthetics company developing brain-computer interface technologies, primarily the Stentrode platform, to restore neurological function in patients with severe neurological disorders. Based in Brooklyn, the company is in early-stage clinical development with a focused pipeline.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Synchron
AI assessmentNot HiringNo open roles listed right now. Follow Synchron to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Motor or sensory imagery with fMRI
Functional NeuroimagingClinical Trials (1)
NCT04723823Sensorimotor Imaging for Brain-Computer Interfaces
N/AHelp build intelligence for Synchron
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.